For example, ASOs for spinal muscular atrophy have demonstrated the ability to change the course of the disease [77–79], and anti-tau therapies have demonstrated a reversal of neurodegeneration in tauopathy mouse models [80, 81]. Here, MAPT is linked to tauopathy.